The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
"Alan sugar good morning won't even sell me one share when I'm checking prices accumulation going on."
Goodo for you, however it's down 16% yesterday and 21% again today. That'd be the same if you sold one share of not
Well this was the worst timed entry I've made in a while, down 20% in a share I've held for 17 market minutes
Well I bought in at the bell yesterday, looks like I may have bought too early.
Never a positive sentiment driver for the directors to sell.
All looking pretty positive
LFT launch Quarter 1
3.5m
Ha, Barnet, that's three boards I've seen you be a tw*t on in under 5 minutes, you need to chill out mate, life will only get better for you if you shrug that negativity.
Have a hug on me .
in £3996 less fees at just under 107p
"I still want to see my STEM shares in my account. Will remain feeling uneasy on that front till I see them. Come on Share Centre bit of catching up to do."
fairly pointless question, but what does everyone thing the price will be one week in?
every time someone has posted NT, I've had an easy quote.
"ODX bouncing back it seems. There is usually a lull before the storm with big rises as seen from many successful investments. Nothing goes up in a straight line."
is it? i see buys going through at under 46p?
i tried to quotes, £3000 and £10000 both came in first time 45.9p and 45.99p
Bank of scotland
you blocked me.
any feedback on that?
News
Covid-19: Government faces legal action over £75m contract for antibody tests
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4427 (Published 12 November 2020)
Cite this as: BMJ 2020;371:m4427
Read our latest coverage of the coronavirus outbreak
Article
Related content
Metrics
Responses
Stephen Armstrong
Author affiliations
Legal action has been launched over the UK government’s award of a £75m (€84m; $99m) contract for one million antibody tests to a business consortium, alleging that the deal unlawfully bypassed safeguards protecting taxpayers’ money.
Judicial review proceedings issued on 11 November by the Good Law Project, a not-for-profit legal organisation, say that the government was actively involved in setting up the UK Rapid Test Consortium and gave it £10m to buy components to manufacture testing kits.
The contract to purchase the AbC-19 Rapid Tests was signed without a public tender and without evaluating the accuracy of the tests, the action says. This, the Good Law Project claim argues, raises serious concerns about the maladministration of public funds.
A study1 published in The BMJ this week questions the accuracy of the AbC-19 test and suggests that, if used in real life settings, the test would result in a large number of false positive results. These conclusions contrast with an earlier (not yet peer reviewed) study suggesting that the test gave no false positive results.
Jolyon Maugham, director of the Good Law Project, said, “However amazed you are by this bestiary of incompetence, you’re not amazed enough. This was a £75m contract, let without competition, on the basis of profoundly flawed research.”
The UK Rapid Testing Consortium was announced by the government on 8 April. The consortium received the £10m in June and was awarded the contract for one million tests on 6 October.
The AbC-19 test was purchased without an open tender under 2015 regulations that, in exceptional circumstances, allow the government “to procure goods, services and works with extreme urgency.”
The Good Law Project needs to obtain the court’s permission to mount these proceedings before the court will look at the lawfulness of the government’s actions in this case.
The Department of Health and Social Care had not responded to requests for comment by the time The BMJ went to press.
"My mate who I gave a tip to, sold this morning at a loss of £2k. She was kinda relying on a profit in these tough times."
tough times and investing on AIM should not be a solution ever considered.
"As a newbie to investing I still fail to understand why a share price falls by almost 20% when high volumes are being traded in a buy/sell ratio of 5:3. It seems to defy page 1 of any textbook on economics and must therefore be due to price manipulation. What is the FCA for?"
well you don't have a accurate representation of buys and sells reported in front of you. you also to know about any delayed transactions at the point of comment, you also do know if the MM's are accumulating or selling, just a few points.
you think?
"Not robust enough."
yes that was my first thought
they could have beefed up the response but at least its out there now.
£2990 less fees at 47.99p.
there were a few NT's when i tried to get that.